SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-008880
Filing Date
2020-04-09
Accepted
2020-04-09 14:29:07
Documents
41
Period of Report
2020-02-29

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0220_bespokeextracts.htm 10-Q 345071
2 CERTIFICATION f10q0220ex31-1_bespoke.htm EX-31.1 9715
3 CERTIFICATION f10q0220ex32-1_bespoke.htm EX-32.1 3697
  Complete submission text file 0001213900-20-008880.txt   2365775

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bspk-20200229.xml EX-101.INS 296271
5 XBRL SCHEMA FILE bspk-20200229.xsd EX-101.SCH 34934
6 XBRL CALCULATION FILE bspk-20200229_cal.xml EX-101.CAL 33290
7 XBRL DEFINITION FILE bspk-20200229_def.xml EX-101.DEF 159465
8 XBRL LABEL FILE bspk-20200229_lab.xml EX-101.LAB 249746
9 XBRL PRESENTATION FILE bspk-20200229_pre.xml EX-101.PRE 206907
Mailing Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160
Business Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 20783984
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences